Does IMATINIB Cause Leukocytosis? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Leukocytosis have been filed in association with IMATINIB (Imatinib). This represents 0.4% of all adverse event reports for IMATINIB.
192
Reports of Leukocytosis with IMATINIB
0.4%
of all IMATINIB reports
43
Deaths
70
Hospitalizations
How Dangerous Is Leukocytosis From IMATINIB?
Of the 192 reports, 43 (22.4%) resulted in death, 70 (36.5%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Leukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which IMATINIB Alternatives Have Lower Leukocytosis Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL